News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Myogen (MYOG) Release: Darusentan Data To Be Presented At American Heart Association 2006 • Chicago



11/6/2006 1:28:20 PM

DENVER--(BUSINESS WIRE)--Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders, today announced that an abstract describing the effects of darusentan on resistant hypertension has been selected for oral presentation at the American Heart Association Scientific Sessions conference to be held Nov. 12-15, 2006, at the McCormick Place Convention Center in Chicago, Ill.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES